What is the 13F Pro Quality Score for ICUI?

13F Pro ranks ICU MEDICAL INC/DE (ICUI) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ICUI's current score at https://13fpro.ai/company/ICUI (free sign-up required for the full ranking).

Which hedge funds own the most ICUI stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of ICUI include BlackRock,, Jupiter Topco, VANGUARD PORTFOLIO MANAGEMENT. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/ICUI as soon as new 13F filings post.

Where does 13F Pro source ICUI data?

All ICU MEDICAL INC/DE fundamentals and ownership data come directly from SEC EDGAR. ICU MEDICAL INC/DE files with the SEC under CIK 883984. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ICUI in?

ICU MEDICAL INC/DE (ICUI) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ICUI research updated on 13F Pro?

ICUI's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

ICU MEDICAL INC/DE(ICUI)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqmid

Institutional-grade research for retail investors

SEC EDGAR: CIK 883984 ICUI stock profile & AI dashboard →

13F Pro Quality Score

49.0/100

Rank #1,687 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

17.9/100

Profitability

48.3/100

Balance Sheet

39.8/100

Earnings Quality

97.4/100

Free Cash Flow

47.9/100

Institutional Flow

68.6/100

Revenue Scale

64.5/100

Dilution Risk

36.3/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why ICUI Scores 49/100

exact factor attribution · 2026-09-11

ICUI's composite is driven by earnings quality and scale, held back by revenue growth and capital efficiency. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings quality

+4.7 pts

97th pct

Scale

+2.2 pts

65th pct

Institutional flow

+0.9 pts

69th pct

Earnings growth

-0.1 pts

47th pct

Profitability

-0.3 pts

48th pct

Free cash flow

-0.3 pts

48th pct

Shareholder dilution

-0.7 pts

36th pct

Capital efficiency

-1.0 pts

40th pct

Revenue growth

-6.4 pts

18th pct

Latest change (2026-08-09): 41 → 48 · ↑ Profit margin 40→65; ↑ Capital efficiency 34→51; despite ↓ Revenue growth 36→26

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

ICUI Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for ICU MEDICAL INC/DE (ICUI), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ICUI at 49.0/100 on a 32-signal composite quality model, placing it at rank #1,687 of 2,962 stocks — the bottom half of the AI-ranked universe. ICUI scores in the top quartile across earnings quality (97.4). Areas of concern include revenue growth (17.9) and balance sheet strength (39.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 36.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ICU MEDICAL INC/DE reports quarterly revenue of $551.7M, net income of $19.1M, an operating margin of 7.1%. Top institutional holders of ICUI by reported 13-F value include BlackRock, Jupiter Topco, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. ICUI trades on the Nasdaq exchange and files with the SEC under CIK 883984. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ICUI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ICU MEDICAL INC/DE directly from SEC EDGAR. ICU MEDICAL INC/DE's 13F Pro composite quality score has ranged between 39 and 52 since 2021, currently 49.0 — a stable long-term trajectory across 68 quarterly and live scoring snapshots.

Revenue

Q2 2026

$551.7M

Net Income

Q2 2026

$19.1M

Free Cash Flow

Q2 2026

$61.6M

Operating Margin

Q2 2026

7.1%

ROIC

Q2 2026

4.6%

D/E Ratio

Q2 2026

0.57

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-6.3% YoY

$2.23BFY 2025

FY22 $2.28BFY23 $2.26BFY24 $2.38BFY25 $2.23B

Net Income

+100.6% YoY

$732.0KFY 2025

FY22 $-74.3MFY23 $-29.7MFY24 $-117.7MFY25 $732.0K

Operating Income

-0.3% YoY

$42.8MFY 2025

FY22 $-42.9MFY23 $22.8MFY24 $43.0MFY25 $42.8M

EPS (Diluted)

+100.6% YoY

$0.03FY 2025

FY22 $-3.11FY23 $-1.23FY24 $-4.83FY25 $0.03

Total Assets

-3.6% YoY

$4.05BFY 2025

FY22 $4.52BFY23 $4.38BFY24 $4.20BFY25 $4.05B

Total Debt

-18.8% YoY

$1.28BFY 2025

FY22 $1.65BFY23 $1.63BFY24 $1.58BFY25 $1.28B

Op. Cash Flow

-11.9% YoY

$179.8MFY 2025

FY22 $-62.1MFY23 $166.2MFY24 $204.0MFY25 $179.8M

Free Cash Flow

-26.4% YoY

$91.8MFY 2025

FY22 $-152.4MFY23 $82.3MFY24 $124.7MFY25 $91.8M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$2.23B -6.3%	$2.38B +5.4%	$2.26B -0.9%	$2.28B +73.2%	$1.32B +3.6%	$1.27B
Net Income	$732.0K +100.6%	$-117.7M -296.9%	$-29.7M +60.1%	$-74.3M -172.0%	$103.1M +18.7%	$86.9M
Operating Income	$42.8M -0.3%	$43.0M +88.2%	$22.8M +153.2%	$-42.9M -134.8%	$123.2M +25.6%	$98.2M
EPS (Diluted)	$0.03 +100.6%	$-4.83 -292.7%	$-1.23 +60.5%	$-3.11 -165.6%	$4.74 +17.9%	$4.02
Total Assets	$4.05B -3.6%	$4.20B -4.0%	$4.38B -3.0%	$4.52B +140.1%	$1.88B +6.6%	$1.76B
Total Debt	$1.28B -18.8%	$1.58B -2.8%	$1.63B -1.5%	$1.65B	$0.00	—
Operating Cash Flow	$179.8M -11.9%	$204.0M +22.8%	$166.2M +367.5%	$-62.1M -123.2%	$267.5M +20.1%	$222.8M
Free Cash Flow	$91.8M -26.4%	$124.7M +51.5%	$82.3M +154.0%	$-152.4M -176.6%	$199.0M +52.2%	$130.7M

Get alerted when ICUI's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ICU MEDICAL INC/DE including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ICUI

BlackRock, Inc.
$550.2M3,753,409 sh
Jupiter Topco LLC
$407.8M2,781,620 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$215.6M1,470,583 sh
FULLER & THALER ASSET MANAGEMENT, INC.
$190.3M1,298,127 sh
VANGUARD CAPITAL MANAGEMENT LLC
$164.7M1,123,237 sh
DIMENSIONAL FUND ADVISORS LP
$154.4M1,053,476 sh
STATE STREET CORP
$150.2M1,024,369 sh
SCHRODER INVESTMENT MANAGEMENT GROUP
$109.3M739,138 sh
AMERIPRISE FINANCIAL INC
$101.1M689,573 sh
GEODE CAPITAL MANAGEMENT, LLC
$96.8M660,423 sh

Fund	Value	Shares
BlackRock, Inc.	$550.2M	3,753,409
Jupiter Topco LLC	$407.8M	2,781,620
VANGUARD PORTFOLIO MANAGEMENT LLC	$215.6M	1,470,583
FULLER & THALER ASSET MANAGEMENT, INC.	$190.3M	1,298,127
VANGUARD CAPITAL MANAGEMENT LLC	$164.7M	1,123,237
DIMENSIONAL FUND ADVISORS LP	$154.4M	1,053,476
STATE STREET CORP	$150.2M	1,024,369
SCHRODER INVESTMENT MANAGEMENT GROUP	$109.3M	739,138
AMERIPRISE FINANCIAL INC	$101.1M	689,573
GEODE CAPITAL MANAGEMENT, LLC	$96.8M	660,423

Companies Similar to ICUI

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

Pediatrix Medical Group, Inc.

AI score

Similar quality profile · 12 shared holders

FULLER & THALER ASSET MANAGEMENT, INC.SILVERCREST ASSET MANAGEMENT GROUP LLC OBERWEIS ASSET MANAGEMENT INC/

NGVT

Ingevity Corp

AI score

Similar quality profile · 8 shared holders

SEGALL BRYANT & HAMILL, LLC WEDGE CAPITAL MANAGEMENT L L P/NC MOODY NATIONAL BANK TRUST DIVISION

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD

AI score

Similar quality profile · 3 shared holders

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC NORDEA INVESTMENT MANAGEMENT AB WCM INVESTMENT MANAGEMENT, LLC

EBS

Emergent BioSolutions Inc.

AI score

Similar quality profile · 4 shared holders

Prosight Management, LP FULLER & THALER ASSET MANAGEMENT, INC.SEGALL BRYANT & HAMILL, LLC

VTRS

Viatris Inc

AI score

Similar quality profile · 3 shared holders

NORDEA INVESTMENT MANAGEMENT AB GAMCO INVESTORS, INC. ET AL WEDGE CAPITAL MANAGEMENT L L P/NC

FTRE

Fortrea Holdings Inc.

AI score

Similar quality profile · 6 shared holders

NORDEA INVESTMENT MANAGEMENT AB SEGALL BRYANT & HAMILL, LLC Hilton Head Capital Partners, LLC

NEOG

NEOGEN CORP

AI score

Similar quality profile · 5 shared holders

KENNEDY CAPITAL MANAGEMENT LLC GAMCO INVESTORS, INC. ET AL FULLER & THALER ASSET MANAGEMENT, INC.

XRAY

DENTSPLY SIRONA Inc.

AI score

Similar quality profile · 7 shared holders

FULLER & THALER ASSET MANAGEMENT, INC.NORDEA INVESTMENT MANAGEMENT AB GAMCO INVESTORS, INC. ET AL

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ICUI on your watchlist

Track score changes the day ICU MEDICAL INC/DE files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ICUI a good stock to buy?

13F Pro's AI-powered analysis of ICU MEDICAL INC/DE (ICUI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ICUI are available on the ICUI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ICUI is classified as a mid company.

Which hedge funds own ICUI?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ICUI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ICU MEDICAL INC/DE's investment landscape.